The objective of this thesis was to investigate the effects of the somatotrope GH/IGF-1 axis upon the thymus. This work included two parts: 1. Translational research study: Thymus function in adult GH deficiency (AGHD) with and without GH treatment Background: Despite age-related adipose involution, T cell generation in the thymus (thymopoiesis) is maintained beyond puberty in adults. In rodents, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and GH secretagogues reverse agerelated changes in thymus cytoarchitecture and increase thymopoiesis. GH administration also enhances thymic mass and function in HIV-infected patients. Until now, thymic function has not been investigated in adult GH deficiency (AGHD). The objective of this clinical study was to evaluate thymic function in AGHD, as well as the repercussion upon thymopoiesis of GH treatment for restoration of GH/IGF-1 physiological levels. Methodology/Principal Findings: Twenty-two patients with documented AGHD were enrolled in this study. The following parameters were measured: plasma IGF-1 concentrations, signal-joint T-cell receptor excision circle (sjTREC) frequency, and sj/b TREC ratio. Analyses were performed at three time points: firstly on GH treatment at maintenance dose, secondly one month after GH withdrawal, and thirdly one month after GH resumption. After 1-month interruption of GH treatment, both plasma IGF-1 concentrations and sjTREC frequency were decreased (p,0.001). Decreases in IGF-1 and sjTREC levels were correlated (r = 0.61, p,0.01). There was also a decrease in intrathymic T cell proliferation as indicated by the reduced sj/b TREC ratio (p,0.01). One month after reintroduction of GH treatment, IGF-1 concentration and sjTREC frequency regained a level equivalent to the one before GH withdrawal. The sj/b TREC ratio also increased with GH resumption, but did not return to the level measured before GH withdrawal. Conclusions: In patients with AGHD under GH treatment, GH withdrawal decreases thymic T cell output, as well as intrathymic T cell proliferation. These parameters of thymus function are completely or partially restored one month after GH resumption. These data indicate that the functional integrity of the somatotrope GH/IGF-1 axis is important for the maintenance of a normal thymus function in human adults. 2. Fundamental study: intrathymic expression of members of the GH/IGF-1 axis and effects of GH on T-cell differentiation in murine fetalthymic organ cultures (FTOC). We here address the question of expression and role of GH/IGF axis in the thymus. Methods: Using RT-qPCR, the expression profile of various components of the somatotrope GH/IGF axis was measured in different thymic cell types and during thymus embryogenesis in Balb/c mice. Effect of GH on T-cell differentiation was explored through thymic organotypic culture. Results: Transcription of Gh, Igf1, Igf2 and their related receptors predominantly occurred in thymic epithelial cells (TEC), while a low level of Gh and Igf1r transcription was also evidenced in thymic T cells (thymocytes). Gh, Ghr, Ins2, Igf1, Igf2, and Igfr1, displayed distinct expression profiles depending on the developmental stage. The protein concentration of IGF-1 and IGF-2 were in accordance with the profile of their gene expression. In fetal thymus organ cultures (FTOC) derived from Balb/c mice, treatment with exogenous GH resulted in a significant increase of double negative CD4-CD8- T cells and CD4+ T cells, with a concomitant decrease in double positive CD4+CD8+ T cells. These changes were inhibited by concomitant treatment with GH and GHR antagonist pegvisomant. However, GH treatment also induced a significant decrease in FTOC Gh, Ghr and Igf1 expression. Conclusion: These data show that the thymotropic properties of the somatotrope GH/IGF-1 axis involve an interaction between exogenous GH and GHR expressed by TEC. Since thymic IGF-1 is not increased by GH treatment, the effects of GH upon T-cell differentiation could implicate a different local growth factor or cytokine.

Für die Untersuchung standen 20 tragende Booroola*Merinofleischschaf Kreuzungsgenotypen, meist pluripar, zwischen 2 und 6 Jahren zur Verfügung. Während der Trächtigkeit wurden in wöchentlichem Abstand die Größenveränderungen der Plazentomdurchmesser mittels transkutaner und transrektaler Ultrasonographie erfasst und Blutproben genommen. Post partum erfolgte die detaillierte Auswertung der Plazenta nach Anzahl und Durchmesser der Kotyledonen und des Kotyledonen- und Sekundinengewichts. Aus den gewonnenen Daten wurden Plazentomwachstumskurven im Verlauf der Trächtigkeit erstellt. Die Blutproben wurden hormonanalytisch auf Progesteron, 17ß-Östradiol, und IGF-1, sowie stoffwechselphysiologisch auf die, den Eiweiß- und Energiehaushalt charakterisierenden Substanzen Albumin, Gesamteiweiß, Harnstoff, BHB, Bilirubin und Glukose untersucht. Zudem erfolgte die Bestimmung von Substanzen, die in der Trächtigkeit stark beansprucht werden, wie ASAT, Calcium, Eisen und Cholesterol. Die Auswertung sämtlicher Daten erfolgte in Abhängigkeit von Wurfgröße (WG) und Wurfgewichtsklassen (WGK). Der größte Einfluss von WG und WGK auf die Plazenta zeigt sich bei der Auswertung der morphologischen Aspekte. Dabei sind in erster Linie eine Vergrößerung der Plazentomdurchmesser von uni- zu triparen Tieren sowie von WGK 1 zur WGK 3 festzustellen. In den jeweils höchsten Klassen fällt der Durchmesser wieder. Zudem nimmt in der Regel mit steigender WG und WGK die Anzahl der Plazentome mit kleinen Durchmessern (1-20 mm)ab, die Anzahl der Plazentome mit großen Durchmessern (20-50 mm) dagegen zu. Tripare Tiere und WGK 3 weisen die meisten Plazentome mit den größten Durchmessern (40-50 mm) auf. Bei der Gesamtkontaktfläche zeigt sich ein Anstieg der Fläche von uni- bis zu quadriparen Tieren und der WGK 1 bis WGK 4. Nur WGK 5 weist eine gegenüber WGK 4 verminderte Gesamtkontaktfläche auf. Unabhängig von WG und WGK verkleinern sich die Plazentomdurchmesser und die Gesamtkontaktflächen p.p. gegenüber den Plazentomdurchmessern und Gesamtkontaktflächen a.p. WG und WGK beeinflussen den Hormonhaushalt mäßig. Dabei zeigt sich der größte Einfluss beim Progesteron. Die kleinste WG bzw. WGK präsentiert die niedrigsten Progesteronkonzentrationen. Beim 17ß-Östradiol ist der Verlauf aller Konzentrationskurven im gesamten Trächtigkeitsverlauf und beim IGF-1 ab dem 100. Tag p.c. einheitlich. Durch WG oder WGK werden bei den Booroola*MF Kreuzungsgenotypen keine den Stoffwechsel charakterisierenden Substanzen in einer auffallenden oder für die Tierart untypischen Weise verändert. Die Anzahl Feten bzw. die WGK zeigen im vorliegenden Datenmaterial keinen gravierenden Einfluss auf den maternalen Stoffwechsel während der Gravidität. / The analysis was founded on 20 pregnant Booroola* Merino Mutton crossbreed sheep between 2 and 6 years, most of them pluriparous. During pregnancy the variations of size of the placentomdiameters were drawn up on a weekly basis using transcutaneous and transrectal ultrasonography. Samples of blood were taken likewise in a weekly rhythm. After birth a detailed examination of the placentae followed, considering especially their number and diameter as well as the weight of the cotyledons and the secundinae. The gained data were used to create placentom-growth-diagrams during pregnancy. The samples of blood were hormonally analysed with regard to progesterone, estradiol and IGF-1 as well as to the substances that characterize the protein- and energy metabolism as there are: albumin, protein, urea, BHB, bilirubin, glucose. Moreover substances which are highly required during pregnancy were determined as e.g. ASAT, calcium, iron, cholesterol. The evaluation of all the gained data was made in dependence on the littersize (LS) and total litterweight (TLW). The major influence of the LS and TLW on the placenta is noticed at the morphological aspects. The placentomdiameter increase from uni- to triparous ewes and from TLW 1 to TLW 3. On the other hand the placentomdiameters decrease in the highest groups. With an increase of LS and TLW the amound of placentoms with small diameters (1-20 mm) generally decreased in favour of the placentoms with big diameters (20-50 mm). Triparous ewes and TLW 3 show most of the placentoms with the largest diameters (40-50 mm). The "total contact area" demonstrates an increase from uni-to quadriparous ewes and TLW 1 to TLW 4. Only TLW 5 has a smaller "total contact area" as TLW 4. Independent of LS and TLW of the Booroola* Merino Mutton crossbreed sheep the placentomdiameter and the "total contact area" decrease p.p. in comparison to the placentomdiameter and "total contact area" a.p. The influence of LS and TLW on the endocrinological system is moderate. The highest influence is proved concerning progesterone, the smallest LS and TLW show the lowest blood-progesterone concentration. In contrast to this, the estradiol concentration of both groups seems to be uniform during the whole pregnancy and equally the IGF-1 concentration from the 100 day p.c. None of the metabolism characterising substances seems to be affected by the LS or TLW. The littersize as well as the litterweight do not influence in the gained data the maternal metabolism during pregnancy.

O tratamento do hipogonadismo hipogonadotrófico na mulher adulta com hipopituitarismo inclui diversas alternativas terapêuticas de estrógenos e progestágenos, sendo a via oral a de menor custo e a de maior comodidade à paciente. A rota estrogênica oral, entretanto, exerce marcada influência sobre o eixo hormônio de crescimento/fator de crescimento insulinasímile número 1 (GH/IGF-1) nessas mulheres. O tratamento com estrógenos orais, concomitante ao uso de GH em pacientes com hipopituitarismo, antagoniza as ações biológicas do GH e agrava as anormalidades de composição corporal e o metabolismo em geral. Presume-se que o estrógeno oral iniba a secreção/produção de IGF-1 através de um efeito de primeira passagem hepática, causando um aumento da secreção de GH através de inibição do feedback negativo de IGF-1 em mulheres normais. Isso é demonstrado clinicamente por redução da massa magra, aumento da massa gorda, perfil lipídico aterogênico e prejuízo do bem-estar psicológico. Alguns estudos apontam que os progestágenos com ação androgênica revertem o efeito de diminuição dos níveis séricos de IGF-1 induzida pelos estrógenos orais. Progestágenos neutros não apresentam esse efeito, porém, quanto maior a potência androgênica, maior será a reversão do efeito de diminuição de IGF-1. Na presente revisão da literatura, serão abordados os aspectos clínicos da reposição com estrógenos e progestágenos nas mulheres com hipopituitarismo, suas interações nas outras deficiências hormonais, bem como o impacto do uso de estrógenos sobre as ações metabólicas do GH. / Treatment of hypogonadotropic hypogonadism in adult woman with hypopituitarism can include a wide range of estrogen and progestogen treatment alternatives, and oral administration is the route of least cost and greatest patient comfort. The oral estrogen route has a major impact on the growth hormone-insulin-like growth factor I (GH-IGF-I) axis. Oral estrogen therapy, when given concurrently with GH to patients with hypopituitarism, antagonizes the biological effects of GH treatment and aggravates the abnormalities of body composition and the metabolism in general. It is presumed that oral estrogen suppresses the secretion/production of IGF-1 by a hepatic first-pass mechanism, resulting in increased GH secretion by means of suppressing the IGF-I negative feedback that is present in healthy women. This is manifest clinically in reduced lean body mass, increased fat mass, an atherogenic lipid profile and damage to psychological well-being. Some studies have indicated that progestogens with androgenic actions reverse the effect of reduced serum IGF-1 levels that is induced by the oral estrogens. Neutral progestogens do not exert this effect, however the stronger the androgenic potential, the more the effect of reduced IGF-1 will be reversed. This bibliographical review will deal with the clinical aspects of estrogen and progestogen replacement in women with hypopituitarism, their interactions with other hormone deficiencies and the impact of estrogen treatment on the metabolic actions of GH.

O tratamento do hipogonadismo hipogonadotrófico na mulher adulta com hipopituitarismo inclui diversas alternativas terapêuticas de estrógenos e progestágenos, sendo a via oral a de menor custo e a de maior comodidade à paciente. A rota estrogênica oral, entretanto, exerce marcada influência sobre o eixo hormônio de crescimento/fator de crescimento insulinasímile número 1 (GH/IGF-1) nessas mulheres. O tratamento com estrógenos orais, concomitante ao uso de GH em pacientes com hipopituitarismo, antagoniza as ações biológicas do GH e agrava as anormalidades de composição corporal e o metabolismo em geral. Presume-se que o estrógeno oral iniba a secreção/produção de IGF-1 através de um efeito de primeira passagem hepática, causando um aumento da secreção de GH através de inibição do feedback negativo de IGF-1 em mulheres normais. Isso é demonstrado clinicamente por redução da massa magra, aumento da massa gorda, perfil lipídico aterogênico e prejuízo do bem-estar psicológico. Alguns estudos apontam que os progestágenos com ação androgênica revertem o efeito de diminuição dos níveis séricos de IGF-1 induzida pelos estrógenos orais. Progestágenos neutros não apresentam esse efeito, porém, quanto maior a potência androgênica, maior será a reversão do efeito de diminuição de IGF-1. Na presente revisão da literatura, serão abordados os aspectos clínicos da reposição com estrógenos e progestágenos nas mulheres com hipopituitarismo, suas interações nas outras deficiências hormonais, bem como o impacto do uso de estrógenos sobre as ações metabólicas do GH. / Treatment of hypogonadotropic hypogonadism in adult woman with hypopituitarism can include a wide range of estrogen and progestogen treatment alternatives, and oral administration is the route of least cost and greatest patient comfort. The oral estrogen route has a major impact on the growth hormone-insulin-like growth factor I (GH-IGF-I) axis. Oral estrogen therapy, when given concurrently with GH to patients with hypopituitarism, antagonizes the biological effects of GH treatment and aggravates the abnormalities of body composition and the metabolism in general. It is presumed that oral estrogen suppresses the secretion/production of IGF-1 by a hepatic first-pass mechanism, resulting in increased GH secretion by means of suppressing the IGF-I negative feedback that is present in healthy women. This is manifest clinically in reduced lean body mass, increased fat mass, an atherogenic lipid profile and damage to psychological well-being. Some studies have indicated that progestogens with androgenic actions reverse the effect of reduced serum IGF-1 levels that is induced by the oral estrogens. Neutral progestogens do not exert this effect, however the stronger the androgenic potential, the more the effect of reduced IGF-1 will be reversed. This bibliographical review will deal with the clinical aspects of estrogen and progestogen replacement in women with hypopituitarism, their interactions with other hormone deficiencies and the impact of estrogen treatment on the metabolic actions of GH.

O tratamento do hipogonadismo hipogonadotrófico na mulher adulta com hipopituitarismo inclui diversas alternativas terapêuticas de estrógenos e progestágenos, sendo a via oral a de menor custo e a de maior comodidade à paciente. A rota estrogênica oral, entretanto, exerce marcada influência sobre o eixo hormônio de crescimento/fator de crescimento insulinasímile número 1 (GH/IGF-1) nessas mulheres. O tratamento com estrógenos orais, concomitante ao uso de GH em pacientes com hipopituitarismo, antagoniza as ações biológicas do GH e agrava as anormalidades de composição corporal e o metabolismo em geral. Presume-se que o estrógeno oral iniba a secreção/produção de IGF-1 através de um efeito de primeira passagem hepática, causando um aumento da secreção de GH através de inibição do feedback negativo de IGF-1 em mulheres normais. Isso é demonstrado clinicamente por redução da massa magra, aumento da massa gorda, perfil lipídico aterogênico e prejuízo do bem-estar psicológico. Alguns estudos apontam que os progestágenos com ação androgênica revertem o efeito de diminuição dos níveis séricos de IGF-1 induzida pelos estrógenos orais. Progestágenos neutros não apresentam esse efeito, porém, quanto maior a potência androgênica, maior será a reversão do efeito de diminuição de IGF-1. Na presente revisão da literatura, serão abordados os aspectos clínicos da reposição com estrógenos e progestágenos nas mulheres com hipopituitarismo, suas interações nas outras deficiências hormonais, bem como o impacto do uso de estrógenos sobre as ações metabólicas do GH. / Treatment of hypogonadotropic hypogonadism in adult woman with hypopituitarism can include a wide range of estrogen and progestogen treatment alternatives, and oral administration is the route of least cost and greatest patient comfort. The oral estrogen route has a major impact on the growth hormone-insulin-like growth factor I (GH-IGF-I) axis. Oral estrogen therapy, when given concurrently with GH to patients with hypopituitarism, antagonizes the biological effects of GH treatment and aggravates the abnormalities of body composition and the metabolism in general. It is presumed that oral estrogen suppresses the secretion/production of IGF-1 by a hepatic first-pass mechanism, resulting in increased GH secretion by means of suppressing the IGF-I negative feedback that is present in healthy women. This is manifest clinically in reduced lean body mass, increased fat mass, an atherogenic lipid profile and damage to psychological well-being. Some studies have indicated that progestogens with androgenic actions reverse the effect of reduced serum IGF-1 levels that is induced by the oral estrogens. Neutral progestogens do not exert this effect, however the stronger the androgenic potential, the more the effect of reduced IGF-1 will be reversed. This bibliographical review will deal with the clinical aspects of estrogen and progestogen replacement in women with hypopituitarism, their interactions with other hormone deficiencies and the impact of estrogen treatment on the metabolic actions of GH.

Philosophiae Doctor - PhD / The aim of this thesis is first, to evaluate various culture conditions to improve embryo development, and secondly, to analyze spent culture media for any biomarkers that may be predictive of embryo health. Single-step and sequential culture media were compared in both Planer and EmbryoScope™ incubators. Single-step media resulted in better blastocyst development compared to sequential media and the EmbryoScope™ incubation system showed slight improvements in embryo development than the Planer system. The benefits of supplementing the culture medium with either insulin or insulin-like growth factor 1 (IGF-1) or culturing in a 2% O2 environment, using two different strains of mice (hybrid and C57), as well as the suitability of these strains for quality control were compared. In insulin, hybrid embryos were slower to blastulate and had a lower blastocyst rate, whereas C57 embryos were slower to the morula and faster to blastocyst stages, and lower blastocyst rate than the controls. IGF-1 showed no difference in time-lapse morphokinetics (TLM) or blastocyst rates compared to controls in both hybrid and C57 embryos. Under 2% O2, hybrid embryos showed no significant difference in TLM up to the 8-cell stage, but slowed down afterwards, resulting in blastocysts with significantly lower cell counts than the 6% O2 group. The C57 embryos were slower to reach morula and expanded blastocyst, and had lower blastocyst rates in 2%O2 vs 6%O2. The C57 strain had significant slower overall embryo development for all time points than hybrid embryos in insulin, IGF-1 and ultra-low O2, as well as lower blastocyst rates. Measurement of growth differentiation factor 9 (GDF-9) and oxidation-reduction potential (ORP) in spent media as markers for embryo health were evaluated. Day 5 human blastocysts yielded higher pregnancy rates and GDF-9 levels in spent media compared to Day 6 blastocysts, but TLM parameters showed no impact on pregnancy outcome. In Day 6 blastocysts, the non-pregnant group showed significantly faster embryo development compared to the clinically pregnant group up to the 8-cell stage and start of blastulation. GDF-9 did not show any significant differences between non-pregnant and pregnant groups of Day 5 or Day 6 embryo transfers. ORP in spent media from good quality Day 3 embryos that developed into blastocysts were significantly higher than from those that did not, with no difference in control medium ORP. Spent media from arrested embryos showed lower ORP than their corresponding controls. Arrested embryos had slower development at syngamy, morula, blastulation and blastocyst stages. The single step medium in the EmbryoScope™ is the preferred choice for embryo culture. Insulin or IGF-1 media supplementation or 2% O2 culture did not provide any benefit to embryo development. The C57 mouse strain is more sensitive and may be better to detect changes in culture conditions, and therefore better model for quality control assays. GDF-9 values decrease from Day 5 to Day 6 which gives new insight to understanding the role of GDF-9 during embryogenesis. ORP in spent media indicate that embryos that developed into blastocysts did not contribute to ROS, but maintained ORP balance.

No description available.

Für die Untersuchung standen 20 tragende Booroola*Merinofleischschaf Kreuzungsgenotypen, meist pluripar, zwischen 2 und 6 Jahren zur Verfügung. Während der Trächtigkeit wurden in wöchentlichem Abstand die Größenveränderungen der Plazentomdurchmesser mittels transkutaner und transrektaler Ultrasonographie erfasst und Blutproben genommen. Post partum erfolgte die detaillierte Auswertung der Plazenta nach Anzahl und Durchmesser der Kotyledonen und des Kotyledonen- und Sekundinengewichts. Aus den gewonnenen Daten wurden Plazentomwachstumskurven im Verlauf der Trächtigkeit erstellt. Die Blutproben wurden hormonanalytisch auf Progesteron, 17ß-Östradiol, und IGF-1, sowie stoffwechselphysiologisch auf die, den Eiweiß- und Energiehaushalt charakterisierenden Substanzen Albumin, Gesamteiweiß, Harnstoff, BHB, Bilirubin und Glukose untersucht. Zudem erfolgte die Bestimmung von Substanzen, die in der Trächtigkeit stark beansprucht werden, wie ASAT, Calcium, Eisen und Cholesterol. Die Auswertung sämtlicher Daten erfolgte in Abhängigkeit von Wurfgröße (WG) und Wurfgewichtsklassen (WGK). Der größte Einfluss von WG und WGK auf die Plazenta zeigt sich bei der Auswertung der morphologischen Aspekte. Dabei sind in erster Linie eine Vergrößerung der Plazentomdurchmesser von uni- zu triparen Tieren sowie von WGK 1 zur WGK 3 festzustellen. In den jeweils höchsten Klassen fällt der Durchmesser wieder. Zudem nimmt in der Regel mit steigender WG und WGK die Anzahl der Plazentome mit kleinen Durchmessern (1-20 mm)ab, die Anzahl der Plazentome mit großen Durchmessern (20-50 mm) dagegen zu. Tripare Tiere und WGK 3 weisen die meisten Plazentome mit den größten Durchmessern (40-50 mm) auf. Bei der Gesamtkontaktfläche zeigt sich ein Anstieg der Fläche von uni- bis zu quadriparen Tieren und der WGK 1 bis WGK 4. Nur WGK 5 weist eine gegenüber WGK 4 verminderte Gesamtkontaktfläche auf. Unabhängig von WG und WGK verkleinern sich die Plazentomdurchmesser und die Gesamtkontaktflächen p.p. gegenüber den Plazentomdurchmessern und Gesamtkontaktflächen a.p. WG und WGK beeinflussen den Hormonhaushalt mäßig. Dabei zeigt sich der größte Einfluss beim Progesteron. Die kleinste WG bzw. WGK präsentiert die niedrigsten Progesteronkonzentrationen. Beim 17ß-Östradiol ist der Verlauf aller Konzentrationskurven im gesamten Trächtigkeitsverlauf und beim IGF-1 ab dem 100. Tag p.c. einheitlich. Durch WG oder WGK werden bei den Booroola*MF Kreuzungsgenotypen keine den Stoffwechsel charakterisierenden Substanzen in einer auffallenden oder für die Tierart untypischen Weise verändert. Die Anzahl Feten bzw. die WGK zeigen im vorliegenden Datenmaterial keinen gravierenden Einfluss auf den maternalen Stoffwechsel während der Gravidität. / The analysis was founded on 20 pregnant Booroola* Merino Mutton crossbreed sheep between 2 and 6 years, most of them pluriparous. During pregnancy the variations of size of the placentomdiameters were drawn up on a weekly basis using transcutaneous and transrectal ultrasonography. Samples of blood were taken likewise in a weekly rhythm. After birth a detailed examination of the placentae followed, considering especially their number and diameter as well as the weight of the cotyledons and the secundinae. The gained data were used to create placentom-growth-diagrams during pregnancy. The samples of blood were hormonally analysed with regard to progesterone, estradiol and IGF-1 as well as to the substances that characterize the protein- and energy metabolism as there are: albumin, protein, urea, BHB, bilirubin, glucose. Moreover substances which are highly required during pregnancy were determined as e.g. ASAT, calcium, iron, cholesterol. The evaluation of all the gained data was made in dependence on the littersize (LS) and total litterweight (TLW). The major influence of the LS and TLW on the placenta is noticed at the morphological aspects. The placentomdiameter increase from uni- to triparous ewes and from TLW 1 to TLW 3. On the other hand the placentomdiameters decrease in the highest groups. With an increase of LS and TLW the amound of placentoms with small diameters (1-20 mm) generally decreased in favour of the placentoms with big diameters (20-50 mm). Triparous ewes and TLW 3 show most of the placentoms with the largest diameters (40-50 mm). The "total contact area" demonstrates an increase from uni-to quadriparous ewes and TLW 1 to TLW 4. Only TLW 5 has a smaller "total contact area" as TLW 4. Independent of LS and TLW of the Booroola* Merino Mutton crossbreed sheep the placentomdiameter and the "total contact area" decrease p.p. in comparison to the placentomdiameter and "total contact area" a.p. The influence of LS and TLW on the endocrinological system is moderate. The highest influence is proved concerning progesterone, the smallest LS and TLW show the lowest blood-progesterone concentration. In contrast to this, the estradiol concentration of both groups seems to be uniform during the whole pregnancy and equally the IGF-1 concentration from the 100 day p.c. None of the metabolism characterising substances seems to be affected by the LS or TLW. The littersize as well as the litterweight do not influence in the gained data the maternal metabolism during pregnancy.

Tillväxthormon och insulinliknande tillväxtfaktor-1 är blodprover som tas vid misstanke om akromegali. Immulite 2000 XPi är ett instrument som använder chemiluminescent microparticle immunoassay metodik för att kvantitativt mäta koncentrationen av GH och IGF-1. Analys av biokemiska markörer påverkas av flera olika faktorer. En viktig sådan faktor är hemolys. Hemolys innebär att de röda blodkropparna går sönder, vilket leder till frisättning av dess innehåll såsom hemoglobin i serum/plasma. Syftet med detta projekt var att undersöka hur hemolys påverkar resultatet av GH- och IGF-1-prover på immulite 2000 XPi. Utifrån erhållna resultat kommer klinisk kemi vid Universitetssjukhuset Örebros laboratorie rutiner vid hemolytiska prover på GH eller IGF-1 att uppdateras . Hemolys tillverkades och tillsattes till olika serumprover med låg och hög nivå av GH respektive IGF-1 för att erhålla prover med varierande grad av hemolys. Resultatet visade att ökande hemolysindex korrelerar med GH- respektive IGF-1-koncentrationer, med undantag för den låga GH koncentrationen som inte uppvisade någon korrelation till hemolysindex. En 10%:ig skillnad av GH och IGF-1- koncentrationer uppnåddes vid en ökning av hemolysindex med 555,40 mg/dL för GH respektive 333,3 mg/dL för IGF-1.Utifrån resultaten var hemolysgränsen likvärdig med tillverkarens gränser. Därför kan klinisk kemi på Universitetssjukhuset Örebro fortsätta med nuvarande hemolysgränser. / Growth hormone and insulin-like growth factor-1 are blood samples taken upon suspicion of acromegaly and for follow-up of acromegaly treatment. Immulite 2000 XPi is an instrument that uses chemiluminescent microparticle immunoassay method to quantitatively measure the concentration of GH and IGF-1. Analysis of biochemical markers is affected by several different factors. An important such factor is hemolysis. Hemolysis means that the red blood cells break, whose contents leak into the serum/plasma. The study aimed to investigate how hemolysis affects the results of GH and IGF-1 samples on the Immulite 2000 XPi. The results will determine the routines for hemolytic samples for GH or IGF-1 at Örebro University Hospital. Hemolysis was produced and added to various serum samples with low and high levels of GH and IGF-1 to obtain samples with varying degrees of hemolysis. The results showed that increasing hemolysis index correlates with GH and IGF-1 concentrations, with the exception of low GH concentration, which did not show any correlation to hemolysis index. A 10% difference in GH and IGF-1 concentrations was achieved with an increase in hemolysis index of 555.40 mg/dL for GH and 333.3 mg/dL for IGF-1. Based on the results, the hemolysis limit was equivalent to the manufacturer's limits. Therefore, clinical chemistry at Örebro University Hospital can continue with current hemolysis limits.

Einleitung: Die konventionelle Milchviehhaltung muss bei steigender Leistung einer artgerechten Tierhaltung und dem Tierwohl gerecht werden. Gleichzeitig ist eine Zunahme von Schwer- und Totgeburten bei hochleistenden Milchrindern zu verzeichnen. Insbesondere Primipara weisen eine deutlich höhere Inzidenz für Dystokien und peripartale Kälberverluste auf als Multipara. Daher steht die endokrine Situation der erstkalbenden Milchrinder und ihrer Kälber im Fokus dieser Studie. Ziel der Untersuchung: Ziel dieser Arbeit war es, den Einfluss und Zusammenhang ausgewählter endokriner Parameter mit dem Kalbeverlauf und dem postnatalen Zustand des Kalbes darzustellen. Dafür wurden die Parameter Progesteron (P4), Östradiol-17β (E2), Cortisol, Insulin, Insulin-like growth factor 1 (IGF-1), Leptin und freie Fettsäuren (NEFA) im peripartalen Zeitraum (14 Tage (d) antepartal (a.p.) bis 3 d postpartal (p.p.) bei den Studientieren aus 4 konventionellen Milchviehbetrieben ausgewertet. Weiterhin wurde der hormonelle Status der geborenen Kälber anhand der Parameter Cortisol, Insulin und IGF-1 untersucht. Zusätzlich erfolgte ein Vergleich zwischen den 4 Milchviehbetrieben mit unterschiedlichen Dystokie- und Verlustraten. Tiere, Material und Methoden: Diese Studie wurde von März 2019 bis Mai 2020 in 4 sächsischen konventionellen Milchviehbetrieben (Betrieb (B) 1 - 4) durchgeführt. Anhand der Kälberverlustraten von 2016 bis 2019 erfolgte bereits eine Kategorisierung in problematische B (B1 und 2) und unproblematische B (B3 und 4). Insgesamt wurden 162 Färsenkalbungen in die Studie eingeschlossen. Zur Erstuntersuchung ca. 14 d a.p. wurden Körpergewicht, Rückenfettdicke (RFD) und Body Condition Score (BCS) erfasst. Die Blutprobenentnahme bei den Färsen erfolgte im Abstand von 2 - 3 d bis zur Kalbung, beim Kalb direkt p.p. sowie 2 - 3 d p.p. bei Färse und Kalb. Das Kälbergeburtsgewicht wurde erfasst und die Kalbungen nach Schwer- und Normalgeburt (SG und NG) sowie Tot- und Lebendgeburt (TG und LG) anhand der endokrinen Parameter ausgewertet. Ergebnisse: Die 162 begleiteten Kalbungen ergaben einen Anteil von 37,1 % SG (B1: 33,3 %, B2: 64,3 %, B3: 23,9 %, B4: 25,0 %; NG: 62,9 %). Die Kategorisierung konnte bestätigt werden, wobei B1 und B2 als problematisch sowie B3 und B4 als unproblematisch eingeordnet wurden. Die TG- Rate lag bei 9,3 % (B1 und B2: je 11,9 %, B3: 4,4 %, B4: 9,3 %; LG: 90,7 %). Es resultierten mehr LG aus NG (94,1 % NG vs. 85,0 % SG) und mehr TG aus SG (15,0 % SG vs. 5,9 % NG). Das Geburtsgewicht hatte keinen Einfluss auf den Kalbeverlauf (p > 0,05). Die problematischen B1 und 2 zeigten ein jüngeres Erstkalbealter mit geringerer Körpermasse und höherer Körperkondition (RFD, BCS) im Vergleich zu den unproblematischen B3 und 4 (p > 0,05). Kontrovers dazu sank mit steigender RFD die Wahrscheinlichkeit für eine SG. Die Hormone P4 und E2 zeigten einen physiologischen Verlauf im peripartalen Zeitraum für alle Studientiere ohne konkreten Zusammenhang mit Kalbeverlauf und Kälbervitalität. Cortisol war bei den Färsen der problematischen B tendenziell zu allen Zeitpunkten höher. Die höchsten Cortisolwerte wurden zur Kalbung, jedoch ohne signifikanten Zusammenhang mit dem Verlauf und Ausgang der Geburt, gemessen. Kälber aus SG hatten direkt p.p. höhere Cortisolwerte als aus NG (p < 0,05). Die stoffwechselassoziierten Parameter (Insulin, IGF-1, Leptin, NEFA) zeigten für alle Studientiere das Vorliegen einer peripartalen negativen Energiebilanz an. Kurz vor der Geburt gingen höhere IGF-1-Werte mit einer sinkenden und höhere NEFA-Werte mit einer steigenden Wahrscheinlichkeit für eine SG einher. Präpartal korrelierten Insulin, IGF-1 und Leptin positiv miteinander (p < 0,05) und negativ mit NEFA (p < 0,05) sowie die Körperkondition positiv mit Insulin (p < 0,001) und Leptin (p < 0,05). Das Insulin der Kälber stieg bis zum 2. - 3. Lebenstag an. Das Kälbergeburtsgewicht korrelierte positiv mit den IGF- 1-Werten der Kälber und den Leptin-Werten der Färsen. Schlussfolgerung: Färsen der problematischen B1 und 2 zeigten zur ersten Kalbung tendenziell eine mangelnde körperliche Entwicklung mit Überkonditionierung. Zusätzlich konnte für diese Tiere eine größere metabolische Belastung mit stärkeren Stressoren festgestellt werden. Diese Faktoren hatten in unserer Studie einen negativen Einfluss auf den Kalbeverlauf und folglich auf die Totgeburtenrate. Eine gute körperliche Entwicklung mit entsprechender Kondition, ein stabiler Stoffwechsel durch adäquate Versorgung, eine stressarme Umgebung und eine optimale prä-, intra- und postpartale Betreuung von Färse und Kalb haben einen positiven Einfluss auf den endokrinen Status der Tiere und letztlich auf die Inzidenz von Schwer- und Totgeburten.